Literature DB >> 8673548

Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms.

J H Burack1, M R Cohen, J A Hahn, D I Abrams.   

Abstract

We wished to determine the short-term safety and efficacy of a Chinese medicinal herb preparation in treating symptoms of human immunodeficiency virus (HIV) infection in a 12-week randomized, double-blind, placebo-controlled clinical trial in a University-affiliated acquired immunodeficiency syndrome (AIDS) clinic at a public general hospital. Thirty adults with symptomatic HIV infection, no previous AIDS-defining diagnosis, and CD4+ counts of 0.200-0.499 x 10(9)/L (200-499/mm3) received 28 tablets each day of either a standardized oral preparation of 31 Chinese herbs or a cellulose placebo. Primary outcome measures were changes in life satisfaction, perceived health, and number and severity of symptoms. Other outcomes included adherence, and changes in weight, CD4+ count, depression, anxiety, physical and social function, and mental health. Two placebo- and no herb-treated subjects had mild adverse events (AE). Subjects on both arms reported taking 94% of prescribed tablets. No differences between treatment groups reached the p < 0.05 level. Life satisfaction improved in herb-treated [+0.86, 95% confidence interval (CI): +0.29, +1.43] but not in placebo-treated subjects (+0.20, 95% CI -0.35, + 0.75). Number of symptoms was reduced in subjects receiving herbs (-2.2, 95% CI -4.1, -0.3) but not in those receiving placebo (-0.3, 95% CI -3.2, +2.7). There were trends toward greater improvements among herb-treated subjects on all symptom subscales except dermatologic. Believing that one was receiving herbs was strongly associated with reporting that the treatment had helped (p < 0.005), but not with changes in life satisfaction or symptoms. There were improvements in life satisfaction and symptoms among subjects receiving the herbal therapy. Whether Chinese herbs are effective in the management of symptomatic HIV infection can be adequately addressed only by larger trials of longer duration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673548     DOI: 10.1097/00042560-199608010-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  5 in total

1.  Racial and socioeconomic disparities in the symptom reporting of persons living with HIV.

Authors:  Rebecca Schnall; Karolynn Siegel; Haomiao Jia; Susan Olender; Sabina Hirshfield
Journal:  AIDS Care       Date:  2018-01-22

Review 2.  Herbal medicines for treating HIV infection and AIDS.

Authors:  J P Liu; E Manheimer; M Yang
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

3.  Traditional Chinese Herbal Medicines for Treating HIV Infections and AIDS.

Authors:  Wen Zou; Ying Liu; Jian Wang; Hongjuan Li; Xing Liao
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-27       Impact factor: 2.629

4.  Aikeqing decreases viral loads in SHIV89.6-infected Chinese rhesus macaques.

Authors:  Gao-Hong Zhang; Jian-Bao Han; Lin Zhu; Rong-Hua Luo; Xi-He Zhang; Xin Chen; Ying-Jie Hu; Lin-Chun Fu; Yong-Tang Zheng
Journal:  Chin Med       Date:  2016-07-01       Impact factor: 5.455

Review 5.  Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.

Authors:  Bahare Salehi; Nanjangud V Anil Kumar; Bilge Şener; Mehdi Sharifi-Rad; Mehtap Kılıç; Gail B Mahady; Sanja Vlaisavljevic; Marcello Iriti; Farzad Kobarfard; William N Setzer; Seyed Abdulmajid Ayatollahi; Athar Ata; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.